122 related articles for article (PubMed ID: 6721624)
1. Correlation of the hemodynamic and pharmacokinetic profile of intravenous milrinone in the anesthetized dog.
Alousi AA; Iwan T; Edelson J; Biddlecome C
Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):59-66. PubMed ID: 6721624
[TBL] [Abstract][Full Text] [Related]
2. Is milrinone equivalent to amrinone during enflurane anesthesia in the dog?
Makela VH; Kapur PA
Anesth Analg; 1988 Apr; 67(4):349-55. PubMed ID: 3354869
[TBL] [Abstract][Full Text] [Related]
3. Cardiotonic and coronary vasodilator responses to milrinone, forskolin, and analog P87-7692 in the anesthetized dog.
Lebedinsky Y; Nordstrom ST; Aschoff SE; Kapples JF; O'Malley GJ; Kosley RW; Fielding S; Hubbard JW
J Cardiovasc Pharmacol; 1992 May; 19(5):779-89. PubMed ID: 1381777
[TBL] [Abstract][Full Text] [Related]
4. [Effects of recombinant human brain natriuretic peptide and milrinone on cardiac hemodynamics and renal function in anesthetized dog].
Xu XW; Yang W; Zhao ZY; Liu HX; Zeng GY
Yao Xue Xue Bao; 2002 Jul; 37(7):506-9. PubMed ID: 12914318
[TBL] [Abstract][Full Text] [Related]
5. Pharmacology of the bipyridines: amrinone and milrinone.
Alousi AA; Johnson DC
Circulation; 1986 Mar; 73(3 Pt 2):III10-24. PubMed ID: 2417744
[TBL] [Abstract][Full Text] [Related]
6. The inotropic and hemodynamic effects of intravenous milrinone when reflex adrenergic stimulation is suppressed by beta-adrenergic blockade.
Travill CM; Pugh S; Noble MI
Clin Ther; 1994; 16(5):783-92. PubMed ID: 7859237
[TBL] [Abstract][Full Text] [Related]
7. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E
Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774
[TBL] [Abstract][Full Text] [Related]
8. [Hemodynamic effects of milrinone in the treatment of cardiac insufficiency after heart surgery with extracorporeal circulation].
Lançon JP; Caillard B; Obadia JF; Pillet M; Leblanc-Beaufils C; Le Bloch Y
Arch Mal Coeur Vaiss; 1991 Nov; 84(11):1575-9. PubMed ID: 1763924
[TBL] [Abstract][Full Text] [Related]
9. A Canadian multicentre study of a 48 h infusion of milrinone in patients with severe heart failure.
Pflugfelder PW; O'Neill BJ; Ogilvie RI; Beanlands DS; Tanser PH; Tihal H; Mizgala HF; Fitchett DH; Kostuk WJ
Can J Cardiol; 1991; 7(1):5-10. PubMed ID: 2025794
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and pharmacodynamics of milrinone in chronic congestive heart failure.
Benotti JR; Lesko LJ; McCue JE; Alpert JS
Am J Cardiol; 1985 Oct; 56(10):685-9. PubMed ID: 4050707
[TBL] [Abstract][Full Text] [Related]
11. In-vivo effects of amrinone and milrinone on left ventricular dP/dt, intraventricular pressure and heart rate in pentobarbital-anesthetized guinea pigs.
Lin BB; Chen HL
Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):237-40. PubMed ID: 1811284
[TBL] [Abstract][Full Text] [Related]
12. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS
J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
[TBL] [Abstract][Full Text] [Related]
13. [Hemodynamic study of intravenous milrinone in 26 patients with NYHA class III or IV cardiac failure].
Boesch C; Dubois-Rande JL; Pochmalicki G; Lellouche D; Teiger E; Saal JP; Cachin JC; Mallo C; Castaigne A; Jan F
Ann Cardiol Angeiol (Paris); 1992 Nov; 41(9):509-12. PubMed ID: 1298193
[TBL] [Abstract][Full Text] [Related]
14. Acute effects of milrinone on the electrocardiogram and the cardiac hemodynamics of rats with pressure overload-induced congestive heart failure.
Desjardins S; Cauchy MJ
Arch Int Pharmacodyn Ther; 1989; 301():182-99. PubMed ID: 2624514
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of intravenous milrinone in the treatment of acute congestive cardiac failure. Results of a French multicenter study].
Dubois-Randé JL; Guérot C; Jan F; Brochier M; Sacrez A; Vacheron A; Bory M; Lambert H; Pony JC; Le Bloc'h Y
Ann Cardiol Angeiol (Paris); 1993 Feb; 42(2):105-14. PubMed ID: 8494318
[TBL] [Abstract][Full Text] [Related]
16. Cardiac and hemodynamic effects of intravenous R 80122, a new phosphodiesterase III inhibitor, in anesthetized and awake dogs.
Van de Water A; d'Aubioul J; Van Gerven W; de Chaffoy de Courcelles D; Freyne E; Xhonneux R; Reneman RS; Janssen PA
Arch Int Pharmacodyn Ther; 1992; 316():60-74. PubMed ID: 1530374
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and pharmacodynamics of milrinone lactate in pediatric patients with septic shock.
Lindsay CA; Barton P; Lawless S; Kitchen L; Zorka A; Garcia J; Kouatli A; Giroir B
J Pediatr; 1998 Feb; 132(2):329-34. PubMed ID: 9506650
[TBL] [Abstract][Full Text] [Related]
18. Effects of milrinone on left ventricular performance and myocardial contractility in patients with severe heart failure.
Sonnenblick EH; Grose R; Strain J; Zelcer AA; LeJemtel TH
Circulation; 1986 Mar; 73(3 Pt 2):III162-7. PubMed ID: 3510772
[TBL] [Abstract][Full Text] [Related]
19. Plasma elimination of milrinone in rats in relation to its hemodynamic effects.
Verrijk R; Vleeming W; van Rooij HH; Wemer J; Porsius AJ
J Pharm Sci; 1990 Mar; 79(3):236-9. PubMed ID: 2338634
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 2nd communication: studies in dogs.
Ohhara H; Ogawa T; Takeda M; Katoh H; Daiku Y; Igarashi T
Arzneimittelforschung; 1989 Jan; 39(1):38-45. PubMed ID: 2719742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
